[Federal Register Volume 88, Number 236 (Monday, December 11, 2023)]
[Notices]
[Pages 85970-85972]
[FR Doc No: 2023-27085]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

[Docket No. DOT-OST-2023-0174]

Notice of Establishment of Aerospace Supply Chain Resiliency Task
Force

AGENCY: Office of the Under Secretary for Transportation Policy,
Department of Transportation (DOT).

ACTION: Notice of the establishment of the Aerospace Supply Chain
Resiliency (ASCR) Task Force.

-----------------------------------------------------------------------

SUMMARY: DOT is announcing the establishment of the ASCR Task Force.
The ASCR Task Force is required by section 106 of the Consolidated
Appropriations Act of 2023, enacted December 29, 2022. This notice
outlines DOT's plan for implementation of this Task Force, including
the dates of Task Force meetings. DOT will publish any future updates
on the DOT web page. See further details within the SUPPLEMENTARY
INFORMATION section of this notice.

DATES: The ASCR Task Force is established on the date of publication of
this Federal Register Notice and will end when the Task Force submits
its report to Congress.

ADDRESSES: The four official meetings of the Task Force will take place
in person at U.S. DOT Headquarters, 1200 New Jersey Avenue SE,
Washington, DC 20590. See Section 6 for further information about the
schedule, location, and nature of the Task Force meetings.

FOR FURTHER INFORMATION CONTACT: Elliott Black, Facilitator, ASCR Task
Force, Office of the Under Secretary for Transportation Policy, at
(202) 924-0588 or email [email protected].

SUPPLEMENTARY INFORMATION: DOT is hereby announcing the establishment
of a new Aerospace Supply Chain Resiliency (ASCR) Task Force. The ASCR
Task Force is required by Section 106 of the Consolidated
Appropriations Act of 2023 (Pub. L. 117-328), enacted December 29,
2022. This notice outlines DOT's plan for implementation of this Task
Force, including the dates of Task Force meetings.
    The remainder of this notice includes:
    1. Summary of statutory requirements (including the scope and
purpose of the new Task Force).
    2. Structure and composition of the Task Force.
    3. Opportunities for others to provide input to the Task Force.
    4. Proceedings, records, and nature of the required reports.
    5. Relationship to other initiatives.
    6. Schedule, location, and nature of the Task Force meetings.
    7. Other Information.

1. Summary of Statutory Requirements

    The statute established the purpose of the Task Force as to
``Identify and assess risks to United States aerospace supply chains,
including the availability of raw materials and critical manufactured
goods, with respect to major end items produced by the aerospace
industry; and the infrastructure of the National Airspace System; and
identify best practices and make recommendations to mitigate those
risks and support a robust United States aerospace supply chain.''
    Accordingly, DOT has established the Task Force as required by the
statute, to focus on the scope as set forth in statute. DOT will
facilitate the Task Force and encourage all members to consider both
current and emerging issues, including issues driven by new and
evolving technologies as well as other external factors and trends.
    The statute also established the maximum size of the Task Force,
and a minimum list of required disciplines to be represented. Please
see Section 2 (``Structure and composition of the Task Force'') for
further information.
    The statute also established several schedule requirements. Please
see Section 5 (``Schedule, location, and nature of the Task Force
meetings'') for further information.
    The statute specifically exempted the Task Force from the Federal
Advisory Committee Act (FACA). Accordingly, this Notice describes the
parameters by which the Task Force will function.

2. Structure and Composition of the Task Force

    The statute outlined 16 specific industry perspectives that must be
represented, including six manufacturing categories, six operational
categories, and four labor categories. The statute requires the
Secretary to appoint ``Individuals with

expertise in logistics, economics, supply chain management, or another
field or discipline related to the resilience of industrial supply
chains.''
    The members of the Task Force are listed below, including both
primary representatives and alternate representatives in case any
primary representative is unavailable to participate in one or more of
the Task Force meetings:
     Sarah MacLeod, Primary member (Christian Klein,
alternate), Aeronautical Repair Station Association (ARSA).
     Dak Hardwick, Primary member (Di Reimold, alternate),
Aerospace Industries Association (AIA).
     Carey Fagan, Primary member (Rugger Smith, alternate), Air
Traffic Control Association (ATCA).
     Richard (Ric) Peri, Primary member (Mike Adamson,
alternate), Aircraft Electronics Association (AEA).
     James (``Jim'') Coon, Primary member (Murray Huling,
alternate), Aircraft Owners and Pilots Association (AOPA).
     Bob Ireland, Primary member (Justin Madden, alternate),
Airlines for America (A4A).
     Michael Robbins, Primary member (Max Rosen, alternate),
Association for Uncrewed Vehicle Systems International (AUVSI).
     Isaiah Wonnenberg, Primary member (Mary Guenther,
alternate), Commercial Spaceflight Federation (CSF).
     Hassan Shahidi, Primary member (Deborah Kirkman,
alternate), Flight Safety Foundation (FSF).
     Paul Feldman, Primary member (Joe Sambiase, alternate),
General Aviation Manufacturers Association (GAMA).
     John Shea, Primary member (Christopher Martino,
alternate), Helicopter Association International (HAI).
     Jody Bennett, Primary member, International Association of
Machinists and Aerospace Workers (IAMAW).
     Richard Plunkett, Primary member (Brandon Anderson,
alternate), International Federation of Professional and Technical
Engineers (IFPTE)/Society of Professional Engineering Employees in
Aerospace (SPEEA).
     Ken Thompson, Primary member (Keith DeBerry, alternate),
National Air Transportation Association (NATA).
     Sierra Grimes, Primary member (Doug Carr, alternate),
National Business Aviation Association (NBAA).
     David Spero, Primary member (Carlos Aguirre, alternate),
Professional Aviation Safety Specialists (PASS).
     Gary Peterson, Primary member (Mark Erler, alternate),
Transport Workers Union of America (TWU).

3. Opportunities for Others To Provide Input to the Task Force

    DOT recognizes that there may be other organizations and
individuals who would like to provide input for consideration by the
Task Force. Each meeting will include a public session where
stakeholders may provide such input. In addition, interested parties
may submit input in writing by following the instructions that DOT has
published at https://www.transportation.gov/ASCR.

4. Proceedings, Records, and Nature of the Required Reports

    Based on the statutory provisions, the Task Force must submit its
Report to Congress within one year of the first meeting of the Task
Force. The Task Force Report to Congress shall be an independent
report, not subject to DOT review or approval.
    Therefore, DOT will facilitate the Task Force proceedings with a
focus on ensuring a balanced and harmonious process, and providing a
safe environment for open dialogue and full consideration of all
perspectives (including addressing input provided by other interested
parties). If there are areas in which the Task Force cannot come to
consensus, DOT will encourage the Task Force to report more than a
single perspective for Congressional consideration.
    DOT will conduct the closed-door portion of Task Force meetings
according to Chatham House rules, which stipulate that the proceedings
are not to be recorded or reported externally in any form. Members of
the Task Force agree not to disclose the internal proceedings or to
attribute any particular viewpoint to any members of the Task Force.
Members of the Task Force will be required to sign Nondisclosure
Agreements. The purpose of this approach is to ensure a safe
environment in which all Members of the Task Force may speak freely and
openly, without fear of external disclosure.
    Likewise, DOT does not intend to record or create detailed minutes,
notes, or other official records of the proceedings, including either
the public sessions or the closed-door sessions. Rather, each Member of
the Task Force shall bear the responsibility to keep their own
individual notes or records as necessary to help them formulate and
prepare the Task Force Report to Congress.
    Based on the statutory provisions, DOT must then submit a separate
Report to Congress, within 180 days of the Task Force report, regarding
the status or implementation of recommendations of the Task Force.
    DOT will post copies of both reports on the website at https://www.transportation.gov/ASCR.

5. Relationship to Other Related Initiatives

    DOT acknowledges that other task forces and other bodies have been
established to examine supply-chain issues, including joint reviews and
reports conducted in response to Executive Order 14017 (entitled
``America's Supply Chains'') as well as other task forces, councils,
and working groups established by other Federal agencies, industry
associations, and other stakeholders.
    DOT will review prior reports and analyses to identify issues that
may need further examination in the particular context of the United
States' aerospace industry. DOT will include such issues on the agenda
for the initial meeting of the Task Force, and engage with Task Force
members as well as other interested parties to consider the challenges
and potential mitigation measures.

6. Schedule, Location, and Nature of the Task Force Meetings

    The official meetings of the Task Force will take place in person
at DOT Headquarters in Washington, DC. Each meeting will include a
public session and a closed-door session. DOT may convene additional
closed-door meetings or working sessions as necessary.
    Parties interested in attending and/or speaking at any of the
public sessions must register at least seven (7) business days in
advance by following the instructions posted at https://www.transportation.gov/ASCR.
    DOT is committed to providing equal access to this meeting for all
participants. If you need alternative formats or services due to a
disability, such as sign language interpretation or other ancillary
aids, please contact the person listed in the FOR FURTHER INFORMATION
CONTACT section at least thirty (30) business days in advance of each
meeting.
    The meetings will take place on the following dates:
     First meeting: Wednesday and Thursday, January 10-11, 2024
(with the public session taking place on Wednesday, January 10, 2024,
from 10:00 a.m. to 12:00 p.m. Eastern time).
     Second meeting: Wednesday and Thursday, April 3-4, 2024
(with the public portion of the meeting taking place on Wednesday,
April 3, 2024,

from 10:00 a.m. to 12:00 p.m. Eastern time).
     Third meeting: Wednesday and Thursday, June 26-27, 2024
(with the public session taking place on Wednesday, June 26, 2024, from
10:00 a.m. to 12:00 p.m. Eastern time).
     Fourth and final meeting: Wednesday and Thursday,
September 18-19, 2024 (with the public portion of the meeting taking
place on Wednesday, September 18, 2024, from 10:00 a.m. to 12:00 p.m.
Eastern time).
    DOT does not anticipate publishing any further notices or
information about this Task Force in the Federal Register. DOT will
post any further information on the Task Force website at https://www.transportation.gov/ASCR.

    Signed in Washington, DC.
Brian Elliott Black,
Facilitator, Aerospace Supply Chain Resiliency Task Force, Office of
the Under Secretary, U.S. Department of Transportation.
[FR Doc. 2023-27085 Filed 12-8-23; 8:45 am]
BILLING CODE 4910-9X-P


[Federal Register Volume 78, Number 243 (Wednesday, December 18, 2013)]
[Proposed Rules]
[Pages 76589-76590]
[FR Doc No: 2013-30135]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[EPA-HQ-OPP-2013-0770; FRL-9904-17]

Notice of Receipt of Several Pesticide Petitions Filed for
Residues of Pesticide Chemicals in or on Various Commodities;
Corrections

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice of filing of petitions; corrections.

-----------------------------------------------------------------------

SUMMARY: EPA issued documents in the Federal Register of July 25, 2012,
and January 16, 2013, concerning a new active ingredient (AI) and
several pesticide petitions (PP) filed for residues of pesticide
chemicals. The name of an AI was changed during the registration
assessment process. This document corrects the name of an AI and also
corrects a PP number.

ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2013-0770, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), EPA West Bldg., Rm. 3334, 1301 Constitution
Ave. NW., Washington, DC 20460-0001. The Public Reading Room is open
from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal
holidays. The telephone number for the Public Reading Room is (202)
566-1744, and the telephone number for the OPP Docket is (703) 305-
5805. Please review the visitor instructions and additional information
about the docket available at http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Robert McNally, Biopesticides and
Pollution Prevention Division (BPPD) (7511P); telephone number: (703)
305-7090; email address<EMAIL_ADDRESS>or Lois Rossi,
Registration Division (RD) (7505P); telephone number:<PHONE_NUMBER>;
email address<EMAIL_ADDRESS>The mailing address for each
contact person is: Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-
0001. As part of the mailing address, include the contact person's
name, division, and mail code. The division to contact is listed at the
end of each correction.

SUPPLEMENTARY INFORMATION:

I. Does this action apply to me?

    The Agency included in the July 25, 2012, and January 16, 2013
documents a list of those who may be potentially affected by this
action.

II. What does this correction do?

    1. EPA-HQ-OPP-2012-0389. In FR Doc. 2012-17899, published in the
Federal Register of July 25, 2012 (77 FR 43562) (FRL-9353-6), is
corrected as follows: On page 43566, under the heading ``New Tolerance
Exemptions,'' third column, paragraph number 4., PP 2F8014, lines 7 and
12, correct ``GS-U-ACTX-Hv1a-SEQ2'' to read ``GS-omega/kappa-Hxtx-
Hv1a.'' (BPPD)
    2. EPA-HQ-OPP-2012-0926. In FR Doc. 2013-00714, published in the
Federal Register of January 16, 2013 (78 FR 3377) (FRL-9375-4), is
corrected as follows: On page 3380, under the heading ``Amended
Tolerances,'' third column, paragraph number 7., line 1, correct ``PP
2F8155'' to read ``PP 2F8115.'' (RD)

List of Subjects in 40 CFR Part 180

    Environmental protection, Agricultural commodities, Feed additives,
Food additives, Pesticides and pests, Reporting and recordkeeping
requirements.

    Dated: December 11, 2013.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.
[FR Doc. 2013-30135 Filed 12-17-13; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register: April 17, 2009 (Volume 74, Number 73)]
[Notices]
[Page 17848-17849]
[DOCID:fr17ap09-54]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP08-458-000]

UGI LNG, Inc.; Notice of Availability of the Environmental
Assessment for the Proposed Temple LNG Plant Expansion Project

April 10, 2009.
    The staff of the Federal Energy Regulatory Commission (FERC or
Commission) has prepared an environmental assessment (EA) on the
expansion of the Temple LNG Plant proposed by UGI LNG, Inc. (UGI LNG)
in the above-referenced docket.
    The EA was prepared to satisfy the requirements of the National
Environmental Policy Act. The staff concludes that approval of the
proposed project, with appropriate mitigating measures, would not
constitute a major federal action significantly affecting the quality
of the human environment.
    The EA assesses the potential environmental effects of the
expansion of UGI LNG's existing liquefied natural gas (LNG) peak-
shaving facility located in Ontelaunee Township, Berks County,
Pennsylvania. Project components include:
     A full-containment LNG storage tank designed to store a
gross volume of 50,000 cubic meters (m\3\) (314,500 barrels) of LNG at
a maximum allowable operating pressure (MAOP) of 2.5 pounds per square
inch (psig);
     A send-out/vaporization system to pressurize and vaporize
the LNG;
     A vapor-handling system to recover and compress vaporized
LNG;
     A tertiary containment system consisting of a system of
swales, earthen berms, bio-retention basin, grading, and concrete
barricades designed to contain the entire contents of the LNG storage
tank; and
     Other LNG storage facility components, including a power
distribution system expansion, a new emergency generator, a control
building addition, a security fence, and access roads.
    UGI LNG states that the project would provide new storage and
peaking distribution of natural gas. It would send out natural gas
through existing Utilities, Inc. and Texas Eastern Transmission Company
pipeline systems.
    All proposed facilities would be constructed and operated in Berks
County, Pennsylvania. UGI LNG proposes beginning construction in 2009
and to have the project in service by November 2011.
    The EA has been placed in the public files of the FERC. A limited
number of copies of the EA are available for distribution and public
inspection at: Federal Energy Regulatory Commission, Public Reference
Room, 888 First Street, NE., Room 2A, Washington, DC 20426, (202) 502-
8371.
    Copies of the EA have been mailed to Federal, State, and local
agencies; public interest groups; interested individuals and affected
landowners; Native American tribes; newspapers and libraries; and
parties to this proceeding.
    Any person wishing to comment on the EA may do so. To ensure
consideration prior to a Commission decision on the proposal, it is
important that we receive your comments before the date specified
below.
    You can make a difference by providing us with your specific
comments or concerns about the Temple LNG Plant Expansion Project. Your
comments should focus on the potential environmental effects,
reasonable alternatives, and measures to avoid or lessen environmental
impacts. The more specific your comments, the more useful they will be.
To ensure that your comments are timely and properly recorded, please
send in your comments so that they will be received in Washington, DC
on or before May 11, 2009.
    For your convenience, there are three methods in which you can use
to submit your comments to the Commission. In all instances please
reference the project docket number CP08-458 with your submission. The
Commission encourages electronic filing of comments and has dedicated
eFiling expert staff available to assist you at<PHONE_NUMBER> or
<EMAIL_ADDRESS>    (1) You may file your comments electronically by using the Quick
Comment feature, which is located on the Commission's Internet Web site
at http://www.ferc.gov under the link to Documents and Filings. A Quick
Comment is an easy method for interested persons to submit text-only
comments on a project;
    (2) You may file your comments electronically by using the eFiling
feature, which is located on the Commission's Internet Web site at
http://www.ferc.gov under the link to Documents and Filings. eFiling
involves

preparing your submission in the same manner as you would if filing on
paper, and then saving the file on your computer's hard drive. You will
attach that file as your submission. New eFiling users must first
create an account by clicking on ``Sign up'' or ``eRegister.'' You will
be asked to select the type of filing you are making. A comment on a
particular project is considered a ``Comment on a Filing;'' or
    (3) You may file your comments via mail to the Commission by
sending an original and two copies of your letter to: Kimberly D. Bose,
Secretary, Federal Energy Regulatory Commission, 888 First St., NE.,
Room 1A, Washington, DC 20426.
    Label one copy of the comments for the attention of Gas Branch 3,
PJ11.3.
    Comments will be considered by the Commission but will not serve to
make the commentor a party to the proceeding. Any person seeking to
become a party to the proceeding must file a motion to intervene
pursuant to Rule 214 of the Commission's Rules of Practice and
Procedures (18 CFR 385.214).\1\ Only intervenors have the right to seek
rehearing of the Commission's decision.
---------------------------------------------------------------------------

    \1\ Interventions may also be filed electronically via the
Internet in lieu of paper. See the previous discussion on filing
comments electronically.
---------------------------------------------------------------------------

    Affected landowners and parties with environmental concerns may be
granted intervenor status upon showing good cause by stating that they
have a clear and direct interest in this proceeding which would not be
adequately represented by any other parties. You do not need intervenor
status to have your comments considered.
    Additional information about the project is available from the
Commission's Office of External Affairs, at 1-866-208-FERC or on the
FERC Internet Web site (http://www.ferc.gov) using the eLibrary link.
Click on the eLibrary link, click on ``General Search'' and enter the
docket number excluding the last three digits in the Docket Number
field. Be sure you have selected an appropriate date range. For
assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at 1-866-208-3676, or for TTY,
contact<PHONE_NUMBER>. The eLibrary link also provides access to the
texts of formal documents issued by the Commission, such as orders,
notices, and rulemakings.
    In addition, the Commission now offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries and direct links to
the documents. Go to http://www.ferc.gov/esubscribenow.htm.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-8811 Filed 4-16-09; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 76, Number 189 (Thursday, September 29, 2011)]
[Notices]
[Page 60516]
[FR Doc No: 2011-25127]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-4031-DR; Docket ID FEMA-2011-0001]

New York; Amendment No. 3 to Notice of a Major Disaster
Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of a major disaster declaration
for the State of New York (FEMA-4031-DR), dated September 13, 2011, and
related determinations.

DATES: Effective Date: September 11, 2011.

FOR FURTHER INFORMATION CONTACT: Peggy Miller, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street, SW.,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Notice is hereby given that the incident
period for this disaster is closed effective September 11, 2011.

    The following Catalog of Federal Domestic Assistance Numbers
(CFDA) are to be used for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster
Unemployment Assistance (DUA); 97.046, Fire Management Assistance
Grant; 97.048, Disaster Housing Assistance to Individuals and
Households In Presidentially Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance--Disaster Housing
Operations for Individuals and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals and Households--Other
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially
Declared Disasters); 97.039, Hazard Mitigation Grant.

    Dated: September 23, 2011.
W. Craig Fugate,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2011-25127 Filed 9-28-11; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register Volume 80, Number 137 (Friday, July 17, 2015)]
[Notices]
[Pages 42584-42587]
[FR Doc No: 2015-17489]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-75434; File No. SR-NYSEArca-2015-57]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
and Immediate Effectiveness of Proposed Rule Change Adding a Pricing
Tier Applicable to Orders of ETP Holders for Tape A, Tape B and Tape C
Securities That Are Eligible To Be Routed Away From the Exchange

July 13, 2015.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 \2\ thereunder, notice is hereby given
that, on June 30, 2015, NYSE Arca, Inc. (the ``Exchange'' or ``NYSE
Arca'') filed with the Securities and Exchange Commission (``SEC'' or
``Commission'') the proposed rule change as described in Items I, II,
and III below, which Items have been prepared by the Exchange. The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to add a pricing tier applicable to orders of
ETP Holders for Tape A, Tape B and Tape C Securities that are eligible
to be routed away from the Exchange. The Exchange proposes to implement
the changes on July 1, 2015. The text of the proposed rule change is
available on the Exchange's Web site at www.nyse.com, at the principal
office of the Exchange, and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to add a pricing tier applicable to orders of
ETP Holders for Tape A, Tape B and Tape C Securities that are eligible
to be routed away from the Exchange (``Routable Orders'').\3\ The
Exchange proposes to implement the fee change on July 1, 2015.
---------------------------------------------------------------------------

    \3\ ETP Holders are able to include an instruction with their
orders to determine whether the order will be eligible to route to
an away exchange (e.g., to execute against trading interest with a
better price than on the Exchange) or, for example, be cancelled if
routing would otherwise occur.
---------------------------------------------------------------------------

    The Exchange proposes a new pricing tier called Routable Retail
Order Tier pursuant to which ETP Holders would receive a credit of
$0.0032 per share for their Routable and non-Routable Orders in Tape A
and Tape C Securities that provide liquidity on the Exchange, and a
credit of $0.0030 per share for their Routable and non-Routable Orders
in Tape B Securities that provide liquidity on the Exchange, if such
ETP Holders, including Market Makers, (1) provide liquidity of 0.20% or
more of U.S. consolidated average daily volume (``U.S. CADV'') during
the billing month across all Tapes, (2) maintain a ratio during the
billing month across all Tapes of executed Routable Orders that provide
liquidity to total executed provide liquidity of 55% or more, and (3)
execute an average daily volume (``ADV'') of Retail Orders \4\ that
provide liquidity during the billing month that is 0.10% or more of the
U.S. CADV. For all other fees and credits, Tiered or Basic Rates apply
based on a firm's qualifying levels.
---------------------------------------------------------------------------

    \4\ Retail Orders are defined in the Fee Schedule as orders
designated as retail orders and that meet the requirements of Rule
7.44(a)(3), but that are not executed in the Retail Liquidity
Program. The Retail Liquidity Program is a pilot program designed to
attract additional retail order flow to the Exchange for NYSE Arca-
listed securities and securities traded pursuant to unlisted trading
privileges while also providing the potential for price improvement
to such order flow. See Rule 7.44. See Securities Exchange Act
Release No. 71176 (December 23, 2013), 78 FR 79524 (December 30,
2013) (SR-NYSEArca-2013-107).
---------------------------------------------------------------------------

    For example, if U.S. CADV during the month is 6.45 billion shares,
the ETP Holder would need to provide liquidity of at least 12.9 million
shares to satisfy the first threshold (i.e., providing liquidity of
0.20% or more of U.S. CADV during the month), which can include Retail
Orders, as well as non-Retail Orders. Additionally, based on a minimum
of 12.9 million shares of required provide liquidity, the ETP Holder
would need to execute at least 7.095 million Routable Orders that
provide liquidity during the month (i.e., maintaining a ratio of
executed Routable Orders that provide liquidity to total executed
orders of 55% or more). Finally, the ETP Holder would need to execute
an ADV of at least 6.45 million Retail Orders that provide liquidity
during the month (i.e., executing an ADV of Retail Orders that provide
liquidity during the billing month that is 0.10% or more of U.S. CADV).
    In connection with the adoption of the Routable Retail Order Tier,
the Exchange proposes to revise the Tape B Step Up Tier, Tape C Step Up
Tier and Tape C Step Up Tier 2.
    Currently, ETP Holders and Market Makers, that, on a daily basis,
measured monthly, directly execute providing volume in Tape B
Securities during a billing month (``Tape B Adding ADV'') that is equal
to at least 0.275% of the U.S. Tape B Consolidated Average Daily Volume
(``Tape B CADV'') for the billing month over the ETP Holder's or Market
Maker's May 2013 Tape B Adding ADV taken as a percentage of Tape B CADV
(``Tape B Baseline % CADV'') receive a credit of $0.0004 per share for
orders that provide liquidity to the Exchange in Tape B Securities,
which is in addition to the ETP Holder's Tiered or Basic Rate
credit(s). The Exchange proposes to specify in the Fee Schedule that
ETP Holders that qualify for the Routable Retail Order Tier would not
be eligible to qualify for the Tape B Step Up Tier. The Exchange
believes that the credit of $0.0030 per share is sufficient that an ETP
Holder that qualifies for the Routable Retail Order Tier should not
also receive the increased credits applicable to the Tape B Step Up
Tier. Similar to Retail Order Tier ETP Holders, Cross-Asset Tier ETP
Holders \5\ and Market Makers, who are currently ineligible to qualify
for the Tape B Step Up Tier, the Exchange proposes to exclude Routable
Retail Order Tier ETP Holders from also qualifying for the Tape B Step
Up Tier.
---------------------------------------------------------------------------

    \5\ The restriction for Cross-Asset Tier ETP Holders from
qualifying for the Tape B Step Up Credit is scheduled to be
implemented on July 1, 2015, subject to the Commission's publication
of the notice for immediate effectiveness of SR-NYSE Arca-2015-55,
filed by the Exchange on June 24, 2015 (``July Fee Filing'').
Exhibit 5 of the instant filing reflects the rule text proposed in
the July Fee Filing.
---------------------------------------------------------------------------

    Additionally, ETP Holders and Market Makers, that, on a daily
basis, measured monthly, directly execute providing volume in Tape C
Securities during the billing month (``Tape C Adding ADV'') that is at
least the greater of (a) the ETP Holder's or Market Maker's January
2012 Tape C Adding ADV (``Tape C Baseline ADV'') plus 0.10% of US Tape
C CADV3 for the billing month or (b) the ETP Holder's or Market Maker's
Tape C Baseline ADV plus 20%, subject to the ETP Holders' and Market
Makers' total providing liquidity in Tape A, Tape B, and Tape C
Securities increasing in an amount no less than 0.03% of US CADV over
their January 2012 providing liquidity receive a lower fee of $0.0029
per share for orders that take liquidity from the Book in Tape C
Securities. The Exchange proposes to specify in the Fee Schedule that
ETP Holders that qualify for the Routable Retail Order Tier would not
be eligible to qualify for the Tape C Step Up Tier. The Exchange
believes that the credit of $0.0032 per share is sufficient that an ETP
Holder that qualifies for the Routable Retail Order Tier should not
also receive the reduced fee applicable to the Tape C Step Up Tier.
Similar to Retail Order Tier ETP Holders, Routable Order Tier ETP
Holders and Market Makers, who are currently ineligible to qualify for
the Tape C Step Up Tier, the Exchange proposes to exclude Routable
Retail Order Tier ETP Holders from also qualifying for the Tape C Step
Up Tier.
    Finally, ETP Holders and Market Makers, that, on a daily basis,
measured monthly, directly execute Tape C Adding ADV during the billing
month that is at least 2 million shares greater than the ETP Holder's
or Market Maker's Tape C Adding ADV during Q2 2012, subject to the ETP
Holder's or Market Maker's combined providing ADV in Tape A, Tape B,
and Tape C Securities during the billing month as a percentage of CADV3
being no less than during Q2 2012 receive a credit of $0.0002 per
share, which is in addition to the ETP Holder's Tiered or Basic Rate
credit(s). The Exchange proposes to specify in the Fee Schedule that
ETP Holders that qualify for the Routable Retail Order Tier would not
be eligible to qualify for the Tape C Step Up Tier 2. The Exchange
believes that the credit

of $0.0030 per share is sufficient that an ETP Holder that qualifies
for the Routable Retail Order Tier should not also receive the
increased credits applicable to the Tape C Step Up Tier 2. Similar to
Retail Order Tier ETP Holders, Routable Order Tier ETP Holders and
Market Makers, who are currently ineligible to qualify for the Tape C
Step Up Tier 2, the Exchange proposes to exclude Routable Retail Order
Tier ETP Holders from also qualifying for the Tape C Step Up Tier 2.
    The Exchange believes that the proposal would create an added
incentive for ETP Holders to bring additional order flow to a public
market.
    The proposed changes are not otherwise intended to address any
other issues, and the Exchange is not aware of any problems that ETP
Holders would have in complying with the proposed changes.
2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) of the Act,\6\ in general, and furthers the
objectives of Sections 6(b)(4) and (5) of the Act,\7\ in particular,
because it provides for the equitable allocation of reasonable dues,
fees, and other charges among its members, issuers and other persons
using its facilities and does not unfairly discriminate between
customers, issuers, brokers or dealers.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78f(b).
    \7\ 15 U.S.C. 78f(b)(4) and (5).
---------------------------------------------------------------------------

    The Exchange believes that the proposed fee change is reasonable
because the proposed Routable Retail Order Tier would contribute to
incentivizing ETP Holders to submit additional orders on the Exchange
that are eligible to be routed away from the Exchange. The Exchange
believes the proposed fee change would increase the liquidity available
on the Exchange because, if a Routable Order were routed and returned
unexecuted, the order would be available for execution on the Exchange.
Therefore, the Exchange believes that Routable Orders add to the
quality of the Exchange's market because they may provide liquidity on
the Exchange of a longer duration. The Routable Retail Order Tier
therefore would support the quality of price discovery and promote
market transparency, thereby benefiting all market participants. In
this regard, the Exchange believes that the rate proposed for the
Routable Retail Order Tier is reasonable because it takes into account
the amount of Routable Orders that an ETP Holder would be required to
execute on the Exchange during a month. The Exchange believes the
proposed fee change is reasonable, equitable and not unfairly
discriminatory because the Routable Retail Order Tier pricing would
apply to executions of Tape A, Tape B and Tape C Securities, and the
Exchange notes that these credits are available on other tiers (e.g.,
$.0.0032 credit for Tape A and C Securities with Arca's Routable Tier,
and $0.0030 credit for Tape B Securities with Cross-Asset Tier).
Furthermore, the Exchange believes it is reasonable and equitable to
apply the Routable Retail Order Tier to Routable and non-Routable
Orders of a qualifying ETP Holder because this would create a further
incentive for ETP Holders to submit Routable Orders to the Exchange.
This is also true because the thresholds applicable to the Routable
Retail Order Tier pertain to liquidity that consists of Routable Orders
as well as the overall liquidity of an ETP Holder, including non-
Routable Orders.
    Furthermore, the Exchange believes that the proposed Routable
Retail Order Tier is equitable and not unfairly discriminatory because
all ETP Holders have the ability to designate their orders as Routable
Orders. Additionally, the proposed credit of $0.0032 per share in Tape
A and Tape C Securities, and $0.0030 per share in Tape B Securities,
for Routable Orders that provide liquidity to the Exchange would be
available to all ETP Holders that qualify for the Routable Retail Order
Tier. The proposed thresholds are also equitable and not unfairly
discriminatory because they are based on objective criteria and the
same criteria would be applicable to all ETP Holders.
    The Exchange believes that prohibiting Routable Retail Order Tier
ETP Holders from qualifying for the Tape B Step Up Tier is reasonable,
equitable and not unfairly discriminatory because ETP Holders that
qualify for the Routable Retail Order Tier would already receive a
higher credit of $0.0030 before the Tape B Step Up Credit, which is
higher than other tiers with the Tape B Step Up credit. For example,
Tier 1 ETP Holders that qualify for Tape B Step Up Tier would receive a
Tier 1 credit of $0.0023 plus a Tape B Step Up credit of $0.0004 for a
total credit of $0.0027, compared with the standalone Routable Retail
Order Tier credit of $0.0030. The Exchange notes that Retail Order ETP
Holders, Cross-Asset Tier ETP Holders and Market Makers currently do
not qualify for Tape B Step Up Tier credit.
    The Exchange further believes that prohibiting Routable Retail
Order Tier ETP Holders from qualifying for the Tape C Step Up Tier is
reasonable, equitable and not unfairly discriminatory because ETP
Holders that qualify for the Routable Retail Order Tier would already
receive a higher credit of $0.0032 before the Tape C Step Up Credit,
which is higher than other tiers that can qualify for the Tape C Step
Up credit. For example, Tier 1 ETP Holders that qualify for Tape C Step
Up Tier would receive a Tier 1 credit of $0.0030 for orders that
provide liquidity, plus a lower Tape C Step Up fee of $0.0029 for
orders that take liquidity from the Book in Tape C Securities, compared
with the standalone Routable Retail Order Tier credit of $0.0032 for
orders that provide liquidity and a fee of $0.0030 share for orders
that take liquidity from the Book in Tape C Securities. The Exchange
notes that Retail Order ETP Holders, Routable Order Tier ETP Holders
and Market Makers currently do not qualify for Tape C Step Up Tier
credit.
    Finally, the Exchange believes that prohibiting Routable Retail
Order Tier ETP Holders from qualifying for the Tape C Step Up Tier 2 is
reasonable, equitable and not unfairly discriminatory because ETP
Holders that qualify for the Routable Retail Order Tier would already
receive a higher credit of $0.0032 before the Tape C Step Up 2 Credit,
which is higher than other tiers with the Tape C Step Up 2 credit. For
example, Tier 1 ETP Holders that qualify for Tape C Step Up 2 Tier
would receive a Tier 1 credit of $0.0030 plus a Tape C Step Up 2 credit
of $0.0002 for a total credit of $0.0032, which is comparable to the
standalone Routable Retail Order Tier credit of $0.0032. The Exchange
notes that Retail Order ETP Holders, Routable Order Tier ETP Holders
and Market Makers currently do not qualify for Tape C Step Up Tier 2
credit.
    Finally, the Exchange believes that it is subject to significant
competitive forces, as described below in the Exchange's statement
regarding the burden on competition. For these reasons, the Exchange
believes that the proposal is consistent with the Act.

B. Self-Regulatory Organization's Statement on Burden on Competition

    In accordance with Section 6(b)(8) of the Act,\8\ the Exchange
believes that the proposed rule change would not impose any burden on
competition that is not necessary or appropriate in furtherance of the
purposes of the Act. Instead, the Exchange believes that the proposed
fee change will encourage competition, including by attracting
additional

liquidity to the Exchange, which will make the Exchange a more
competitive venue for, among other things, order execution and price
discovery. In general, ETP Holders impacted by the proposed change may
readily adjust their trading behavior to maintain or increase their
credits or decrease their fees in a favorable manner, and will
therefore not be disadvantaged in their ability to compete.
Specifically, an ETP Holder could qualify for the proposed new Routable
Retail Order Type by providing sufficient liquidity to satisfy the
applicable proposed volume requirements. Additionally, all ETP Holders
have the ability to designate their orders as Routable Orders and
therefore any ETP Holder could qualify for the proposed Routable Retail
Order Tier by satisfying the proposed liquidity thresholds.
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78f(b)(8).
---------------------------------------------------------------------------

    Finally, the Exchange notes that it operates in a highly
competitive market in which market participants can readily favor
competing venues. In such an environment, the Exchange must continually
review, and consider adjusting, its fees and credits to remain
competitive with other exchanges. For the reasons described above, the
Exchange believes that the proposed rule change promotes a competitive
environment.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change is effective upon filing pursuant to
Section 19(b)(3)(A) \9\ of the Act and subparagraph (f)(2) of Rule 19b-
4 \10\ thereunder, because it establishes a due, fee, or other charge
imposed by the Exchange.
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78s(b)(3)(A).
    \10\ 17 CFR 240.19b-4(f)(2).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings under
Section 19(b)(2)(B) \11\ of the Act to determine whether the proposed
rule change should be approved or disapproved.
---------------------------------------------------------------------------

    \11\ 15 U.S.C. 78s(b)(2)(B).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-NYSEArca-2015-57 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEArca-2015-57. This
file number should be included on the subject line if email is used. To
help the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Room, 100 F Street NE.,
Washington, DC 20549, on official business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the filing also will be available
for inspection and copying at the principal office of the Exchange. All
comments received will be posted without change; the Commission does
not edit personal identifying information from submissions. You should
submit only information that you wish to make available publicly. All
submissions should refer to File Number SR-NYSEArca-2015-57 and should
be submitted on or before August 7, 2015.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\12\
---------------------------------------------------------------------------

    \12\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Brent J. Fields,
Secretary.
[FR Doc. 2015-17489 Filed 7-16-15; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)]
[Notices]
[Pages 52947-52953]
[FR Doc No: 2016-18984]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2016-0216]

Qualification of Drivers; Exemption Applications; Diabetes
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA).

ACTION: Notice of applications for exemptions; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 46 individuals
for exemption from the prohibition against persons with insulin-treated
diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in
interstate commerce. If granted, the exemptions would enable these
individuals with ITDM to operate CMVs in interstate commerce.

DATES: Comments must be received on or before September 9, 2016.

ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket No. FMCSA-2016-0216 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    Instructions: Each submission must include the Agency name and the
docket numbers for this notice. Note that all comments received will be
posted without change to http://www.regulations.gov, including any
personal information provided. Please see the Privacy Act heading below
for further information.
    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The Federal Docket Management System (FDMS) is
available 24 hours each day, 365 days each year. If you want
acknowledgment that we received your comments, please include a self-
addressed, stamped envelope or postcard or print the acknowledgement
page that appears after submitting comments on-line.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to www.regulations.gov, as described in the
system of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.

FOR FURTHER INFORMATION CONTACT: Christine A. Hydock, Chief, Medical
Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113,
Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t.,
Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

I. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the Federal Motor Carrier Safety Regulations for a 2-year period
if it finds ``such exemption would likely achieve a level of safety
that is equivalent to or greater than the level that would be achieved
absent such exemption.'' The statute also allows the Agency to renew
exemptions at the end of the 2-year period. The 46 individuals listed
in this notice have recently requested such an exemption from the
diabetes prohibition in 49 CFR 391.41(b)(3), which applies to drivers
of CMVs in interstate commerce. Accordingly, the Agency will evaluate
the qualifications of each applicant to determine whether granting the
exemption will achieve the required level of safety mandated by
statute.

II. Qualifications of Applicants

Dale E. Bliss

    Mr. Bliss, 63, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Bliss understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Bliss meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Wisconsin.

Charles W. Bobbitt, III

    Mr. Bobbitt, 52, has had ITDM since 1986. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Bobbitt understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Bobbitt meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Washington.

Thomas Buckmaster

    Mr. Buckmaster, 58, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of

consciousness, requiring the assistance of another person, or resulting
in impaired cognitive function that occurred without warning in the
past 12 months and no recurrent (2 or more) severe hypoglycemic
episodes in the last 5 years. His endocrinologist certifies that Mr.
Buckmaster understands diabetes management and monitoring, has stable
control of his diabetes using insulin, and is able to drive a CMV
safely.
    Mr. Buckmaster meets the requirements of the vision standard at 49
CFR 391.41(b)(10). His ophthalmologist examined him in 2015 and
certified that he does not have diabetic retinopathy. He holds a Class
A CDL from Florida.

Dustin L. Campbell

    Mr. Campbell, 31, has had ITDM since 1994. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Campbell understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Campbell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Maryland.

Keith A. Cederberg

    Mr. Cederberg, 58, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Cederberg understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Cederberg meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Minnesota.

Carlos A. Chapa

    Mr. Chapa, 44, has had ITDM since 2013. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Chapa understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Chapa meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Texas.

David E. Colorado

    Mr. Colorado, 42, has had ITDM since 2010. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Colorado understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Colorado meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Utah.

Francis J. Crawford

    Mr. Crawford, 33, has had ITDM since 2000. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Crawford understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Crawford meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from New York.

James W. Creech

    Mr. Creech, 67, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Creech understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Creech meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Indiana.

Kirk A. Devitis

    Mr. Devitis, 46, has had ITDM since 2006. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Devitis understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Devitis meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds an operator's license
from New Jersey.

Melinda L. Echols

    Ms. Echols, 50, has had ITDM since 2016. Her endocrinologist
examined her in 2016 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
Her endocrinologist certifies that Ms. Echols understands diabetes
management and monitoring has stable control of her diabetes using
insulin, and is able to drive a CMV safely. Ms. Echols meets the
requirements of the

vision standard at 49 CFR 391.41(b)(10). Her ophthalmologist examined
her in 2016 and certified that she has stable nonproliferative diabetic
retinopathy. She holds a Class A CDL from Washington.

Justin W. Garriott

    Mr. Garriott, 44, has had ITDM since 1998. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Garriott understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Garriott meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Wyoming.

David J. Goergen

    Mr. Goergen, 40, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Goergen understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Goergen meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Minnesota.

Pedro L. Gonzalez

    Mr. Gonzalez, 56, has had ITDM since 1999. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Gonzalez understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Gonzalez meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Massachusetts.

Jeffrey K. Hagen

    Mr. Hagen, 57, has had ITDM since 2009. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Hagen understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hagen meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Wisconsin.

Charles D. Hall

    Mr. Hall, 61, has had ITDM since 2012. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Hall understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Hall meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from California.

Daniel O. Hawley

    Mr. Hawley, 59, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Hawley understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hawley meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Illinois.

Eugene R. Huelskamp

    Mr. Huelskamp, 53, has had ITDM since 1974. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Huelskamp understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Huelskamp meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
proliferative diabetic retinopathy. He holds a Class A CDL from Ohio.

Dennis S. Hughes

    Mr. Hughes, 60, has had ITDM since 2008. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Hughes understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hughes meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds a Class B CDL from Texas.

Bonita K. Hunt

    Ms. Hunt, 49, has had ITDM since 2015. Her endocrinologist examined
her in 2016 and certified that she has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no

recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
Her endocrinologist certifies that Ms. Hunt understands diabetes
management and monitoring has stable control of her diabetes using
insulin, and is able to drive a CMV safely. Ms. Hunt meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). Her
ophthalmologist examined her in 2016 and certified that she does not
diabetic retinopathy. She holds a Class C CDL from North Carolina.

John M. Isley

    Mr. Isley, 47, has had ITDM since 2009. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Isley understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Isley meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2015 and certified that he does not have
diabetic retinopathy. He holds an operator's license from North
Carolina.

John T. Jameson

    Mr. Jameson, 81, has had ITDM since 2005. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Jameson understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Jameson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds an operator's license from
Missouri.

Jeffrey A. Kidd

    Mr. Kidd, 53, has had ITDM since 2013. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Kidd understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Kidd meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds an operator's license from Maryland.

Craig T. Kite

    Mr. Kite, 51, has had ITDM since 2012. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Kite understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Kite meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class B CDL from Ohio.

Donald E. Knowles

    Mr. Knowles, 54, has had ITDM since 2016. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Knowles understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Knowles meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Iowa.

Kevin E. Lester

    Mr. Lester, 50, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Lester understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Lester meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Virginia.

Eric T. Maier

    Mr. Maier, 52, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Maier understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Maier meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from California.

Javier Melendez

    Mr. Melendez, 56, has had ITDM since 2007. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Melendez understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Melendez meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds an operator's license from Texas.

Brenda L. Mitchell

    Ms. Mitchell, 67, has had ITDM since 2012. Her endocrinologist
examined her in 2016 and certified that she has had no severe
hypoglycemic reactions

resulting in loss of consciousness, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning in the past 12 months and no recurrent (2 or more)
severe hypoglycemic episodes in the last 5 years. Her endocrinologist
certifies that Ms. Mitchell understands diabetes management and
monitoring has stable control of her diabetes using insulin, and is
able to drive a CMV safely. Ms. Mitchell meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). Her optometrist examined her
in 2016 and certified that she does not have diabetic retinopathy. She
holds an operator's license from Kentucky.

Terry L. Neiman

    Mr. Neiman, 65, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Neiman understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Neiman meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Pennsylvania.

Peter Z. Pall

    Mr. Pall, 52, has had ITDM since 2010. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Pall understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Pall meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds an operator's license from Florida.

Joaquim Pedro

    Mr. Pedro, 36, has had ITDM since 2007. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Pedro understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Pedro meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds a Class B CDL from New York.

Vernon Piper

    Mr. Piper, 59, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Piper understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Piper meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from New York.

Angelo Renieris

    Mr. Renieris, 37, has had ITDM since 1982. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Renieris understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Renieris meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class B CDL from New
York.

Sean A. Rivera

    Mr. Rivera, 28, has had ITDM since 2004. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Rivera understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Rivera meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Arizona.

Kevin L. Ross

    Mr. Ross, 42, has had ITDM since 2016. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Ross understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Ross meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from Alaska.

James R. Sauceda

    Mr. Sauceda, 40, has had ITDM since 2014. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Sauceda understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Sauceda meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable

nonproliferative diabetic retinopathy. He holds a Class A CDL from New
Mexico.

Kevin Stead

    Mr. Stead, 49, has had ITDM since 2006. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Stead understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Stead meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from New Jersey.

Jacob P. Trommer

    Mr. Trommer, 22, has had ITDM since 2001. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Trommer understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Trommer meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Ohio.

Nicholas D. Wall

    Mr. Wall, 25, has had ITDM since 2000. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Wall understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Wall meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds an operator's license from South Dakota.

Tony B. Wetherell

    Mr. Wetherell, 51, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Wetherell understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Wetherell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Minnesota.

Mark A. Williams

    Mr. Williams, 55, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Williams understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Williams meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds an operator's license
from Georgia.

Steven M. Wilson

    Mr. Wilson, 56, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Wilson understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Wilson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Illinois.

Don E. Wood, Jr.

    Mr. Wood, 53, has had ITDM since 2015. His endocrinologist examined
him in 2016 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the last 5 years. His
endocrinologist certifies that Mr. Wood understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Wood meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined
him in 2016 and certified that he does not have diabetic retinopathy.
He holds an operator's license from Texas.

Kirk M. Wright

    Mr. Wright, 36, has had ITDM since 2003. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist certifies that Mr. Wright understands diabetes
management and monitoring, has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Wright meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Nebraska.

Charles P. Zenns

    Mr. Zenns, 50, has had ITDM since 2015. His endocrinologist
examined him in 2016 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the last 5 years.
His endocrinologist

certifies that Mr. Zenns understands diabetes management and
monitoring, has stable control of his diabetes using insulin, and is
able to drive a CMV safely. Mr. Zenns meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2016 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from New York.

III. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the date section
of the notice.
    FMCSA notes that section 4129 of the Safe, Accountable, Flexible
and Efficient Transportation Equity Act: A Legacy for Users requires
the Secretary to revise its diabetes exemption program established on
September 3, 2003 (68 FR 52441).\1\ The revision must provide for
individual assessment of drivers with diabetes mellitus, and be
consistent with the criteria described in section 4018 of the
Transportation Equity Act for the 21st Century (49 U.S.C. 31305).
---------------------------------------------------------------------------

    \1\ Section 4129(a) refers to the 2003 notice as a ``final
rule.'' However, the 2003 notice did not issue a ``final rule'' but
did establish the procedures and standards for issuing exemptions
for drivers with ITDM.
---------------------------------------------------------------------------

    Section 4129 requires: (1) Elimination of the requirement for 3
years of experience operating CMVs while being treated with insulin;
and (2) establishment of a specified minimum period of insulin use to
demonstrate stable control of diabetes before being allowed to operate
a CMV.
    In response to section 4129, FMCSA made immediate revisions to the
diabetes exemption program established by the September 3, 2003 notice.
FMCSA discontinued use of the 3-year driving experience and fulfilled
the requirements of section 4129 while continuing to ensure that
operation of CMVs by drivers with ITDM will achieve the requisite level
of safety required of all exemptions granted under 49 U.S.C. 31136(e).
    Section 4129(d) also directed FMCSA to ensure that drivers of CMVs
with ITDM are not held to a higher standard than other drivers, with
the exception of limited operating, monitoring and medical requirements
that are deemed medically necessary.
    The FMCSA concluded that all of the operating, monitoring and
medical requirements set out in the September 3, 2003 notice, except as
modified, were in compliance with section 4129(d). Therefore, all of
the requirements set out in the September 3, 2003 notice, except as
modified by the notice in the Federal Register on November 8, 2005 (70
FR 67777), remain in effect.

IV. Submitting Comments

    You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov and
in the search box insert the docket number FMCSA-2016-0216 and click
the search button. When the new screen appears, click on the blue
``Comment Now!'' button on the right hand side of the page. On the new
page, enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope.
    We will consider all comments and material received during the
comment period. FMCSA may issue a final determination at any time after
the close of the comment period.

V. Viewing Comments and Documents

    To view comments, as well as any documents mentioned in this
preamble, go to http://www.regulations.gov and in the search box insert
the docket number FMCSA-2016-0216 and click ``Search.'' Next, click
``Open Docket Folder'' and you will find all documents and comments
related to this notice.

    Issued on: August 1, 2016.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2016-18984 Filed 8-9-16; 8:45 am]
 BILLING CODE 4910-EX-P